Literature DB >> 21450943

Effects of N-linked glycosylation of the fusion protein on replication of human metapneumovirus in vitro and in mouse lungs.

Jinhui Zhang1, Ying Dou1, Junfeng Wu1, Weiwei She1, Lizhong Luo2, Yao Zhao1, Ping Liu1, Xiaodong Zhao1.   

Abstract

The fusion (F) protein is an important membrane glycoprotein necessary for cellular entry and replication of human metapneumovirus (hMPV). Selective prevention of N-linked glycosylation may compromise the catalytic and fusion functions of the F protein. By using site-directed mutagenesis and reverse genetics, recombinant mutant viruses lacking one or two N-linked glycosylation sites in the F protein were constructed. M1, which lacked glycosylation at position 57 of the F protein, had slightly compromised replication, whereas M2 and M4, which lacked glycosylation at position(s) 172 or 57 and 172, respectively, showed profound impairment of replication when compared with wild-type (WT) NL/1/00-GFP virus in both Vero E6 cells and mouse lungs. M2 was less fit than WT virus in vitro and in immunocompromised mouse lungs. The F proteins of WT and mutant viruses were similarly expressed on the infected cell membrane, while the activated fusion protein subunits, F1 of M2 and M4, were produced in lower quantities compared with those of WT and M1 virus. The mutated viruses lacking N-linked glycosylation at position 353, either individually or together with other sites, could not be recovered. Thus, N-linked glycosylation may be involved in the catalysis of the fusion protein from F0 to F1 and F2, which is critical for fusion function. Strategies targeting N-linked glycosylation may be helpful for developing attenuated live vaccines or antiviral drugs for hMPV.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21450943     DOI: 10.1099/vir.0.030049-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  8 in total

1.  Human metapneumovirus infection of airway epithelial cells is associated with changes in core metabolic pathways.

Authors:  Yanhua Zhao; Harendra Singh Chahar; Narayana Komaravelli; Anar Dossumekova; Antonella Casola
Journal:  Virology       Date:  2019-03-22       Impact factor: 3.616

Review 2.  Development and application of reporter-expressing mononegaviruses: current challenges and perspectives.

Authors:  Darryl Falzarano; Allison Groseth; Thomas Hoenen
Journal:  Antiviral Res       Date:  2014-01-23       Impact factor: 5.970

3.  A live attenuated human metapneumovirus vaccine strain provides complete protection against homologous viral infection and cross-protection against heterologous viral infection in BALB/c mice.

Authors:  Ping Liu; Zhou Shu; Xian Qin; Ying Dou; Yao Zhao; Xiaodong Zhao
Journal:  Clin Vaccine Immunol       Date:  2013-06-12

Review 4.  Immune Response to Human Metapneumovirus Infection: What We Have Learned from the Mouse Model.

Authors:  Nagarjuna R Cheemarla; Antonieta Guerrero-Plata
Journal:  Pathogens       Date:  2015-09-18

5.  Addicted to sugar: roles of glycans in the order Mononegavirales.

Authors:  Victoria Ortega; Jacquelyn A Stone; Erik M Contreras; Ronald M Iorio; Hector C Aguilar
Journal:  Glycobiology       Date:  2019-01-01       Impact factor: 4.313

6.  The role of lipid rafts in cell entry of human metapneumovirus.

Authors:  Suhua Chen; Hao He; Hui Yang; Bin Tan; Enmei Liu; Xiaodong Zhao; Yao Zhao
Journal:  J Med Virol       Date:  2019-02-20       Impact factor: 2.327

Review 7.  Breaking in: human metapneumovirus fusion and entry.

Authors:  Reagan G Cox; John V Williams
Journal:  Viruses       Date:  2013-01-16       Impact factor: 5.048

Review 8.  Human metapneumovirus - what we know now.

Authors:  Nazly Shafagati; John Williams
Journal:  F1000Res       Date:  2018-02-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.